VI
VenoStent, Inc.
SEC filingOther Health Care · Houston, TX
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise29count reported to the SEC
FiledMay 1, 2026first sale Apr 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Geoffrey LucksExecutive Officer, Director
Joel WhitleyDirector
Timothy BoireExecutive Officer, Director
Jim MonsorDirector
Robert CrutchfieldDirector
Executive officers, directors and promoters as listed on the Form D.